IRIS
SAMBATARO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.553
AS - Asia 1.651
SA - Sud America 558
EU - Europa 434
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 41
OC - Oceania 1
Totale 6.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.450
SG - Singapore 615
BR - Brasile 463
HK - Hong Kong 395
CN - Cina 167
BD - Bangladesh 147
IT - Italia 140
VN - Vietnam 139
IE - Irlanda 81
TR - Turchia 51
DE - Germania 43
CA - Canada 39
GB - Regno Unito 38
MX - Messico 38
FR - Francia 35
AR - Argentina 32
IN - India 32
PL - Polonia 21
ID - Indonesia 20
CO - Colombia 17
EC - Ecuador 16
ZA - Sudafrica 16
RU - Federazione Russa 15
ES - Italia 13
IQ - Iraq 11
JP - Giappone 11
SA - Arabia Saudita 11
NL - Olanda 10
UA - Ucraina 9
PY - Paraguay 8
MA - Marocco 7
VE - Venezuela 7
AT - Austria 6
EG - Egitto 6
HN - Honduras 6
PH - Filippine 6
PK - Pakistan 6
UZ - Uzbekistan 6
CL - Cile 5
KZ - Kazakistan 5
MY - Malesia 5
PE - Perù 5
SE - Svezia 5
FI - Finlandia 4
QA - Qatar 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CR - Costa Rica 3
ET - Etiopia 3
NP - Nepal 3
AL - Albania 2
AZ - Azerbaigian 2
BZ - Belize 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 6.238
Salva come PNG Salva come JPEG
Città #
Dallas 1.380
Hong Kong 394
San Jose 361
Singapore 291
Ashburn 232
Santa Clara 161
Chicago 127
The Dalles 121
Council Bluffs 81
Dublin 81
Beijing 58
New York 54
Phoenix 53
Ho Chi Minh City 51
Istanbul 39
Los Angeles 32
São Paulo 30
Hanoi 29
Hillsboro 22
Assago 20
Mexico City 20
Warsaw 19
Abbeville 17
Rio de Janeiro 17
Brooklyn 15
Princeton 15
Rome 15
Milan 14
Montreal 14
Toronto 13
San Francisco 11
Belo Horizonte 10
Philadelphia 10
Tokyo 10
Catania 9
Düsseldorf 9
Johannesburg 9
Manchester 9
Palermo 9
Seattle 9
Atlanta 8
Brasília 8
Buffalo 8
Charlotte 8
Denver 8
Frankfurt am Main 8
London 8
Naples 8
Porto Alegre 8
Biên Hòa 7
Boston 7
Curitiba 7
Dhaka 7
Chennai 6
Hải Dương 6
Manaus 6
Medellín 6
The Bronx 6
Thái Bình 6
Ankara 5
Guayaquil 5
Jeddah 5
Las Vegas 5
Lima 5
Limburg an der Lahn 5
Limeira 5
Maceió 5
Nova Iguaçu 5
Reston 5
Thái Nguyên 5
Asunción 4
Baghdad 4
Camaçari 4
Campinas 4
Caxias do Sul 4
Cleveland 4
Doha 4
Fortaleza 4
Helsinki 4
Jakarta 4
Lauterbourg 4
Orem 4
Salvador 4
Santo André 4
Stockholm 4
São Bernardo do Campo 4
Tampa 4
Tashkent 4
Washington 4
Wilmington 4
Addis Ababa 3
Araraquara 3
Bogotá 3
Buenos Aires 3
Cape Town 3
Caracas 3
Cariacica 3
Casablanca 3
Cuiabá 3
Da Nang 3
Totale 4.172
Salva come PNG Salva come JPEG
Nome #
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 88
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 88
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 85
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 85
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 83
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 78
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 74
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 73
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project 72
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 71
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 70
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 70
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study 69
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 68
COVAD survey 2 long-term outcomes: unmet need and protocol 67
Autoimmunity in interstitial lung disease 67
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 66
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 65
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 65
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 64
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 64
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group 63
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 63
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 62
A die-hard giant capillary 62
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 62
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 62
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 61
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project 61
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 61
Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss 58
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply 58
Pulmonary vasculitides: A radiological review emphasizing parenchymal hrct features 58
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 58
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 57
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 57
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 57
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 56
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 55
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 55
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 55
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 55
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 54
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 54
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 54
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course 53
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 53
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 53
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 53
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 52
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 52
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey 51
Quantitative evaluation of fibrosis in ipf patients: Meaning of diffuse pulmonary ossification 51
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 51
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 51
Hepatic PPARs: Their role in liver physiology, fibrosis and treatment 50
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 50
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 49
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 49
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 49
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 49
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 49
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 48
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: A comparative analysis of the COVAD surveys 48
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 48
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 47
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 46
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 46
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 45
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 45
Developing PI3K Inhibitors for Respiratory Diseases 45
Comorbidities of IPF: How do they impact on prognosis 45
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives 45
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 45
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 45
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 44
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: Results from the COVAD study 44
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 44
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 44
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 43
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome 43
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? 42
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? 42
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 42
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 41
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 41
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 41
Highlights on Future Treatments of IPF: Clues and Pitfalls 40
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 40
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 40
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 39
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 39
Eosinophilic Interstitial Pneumonia 39
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 39
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 39
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study 39
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys 38
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 37
COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19 37
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 37
Totale 5.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.523 0 0 0 0 334 287 113 127 156 189 203 114
2025/20264.251 214 941 699 543 69 144 325 318 380 297 212 109
2026/2027622 53 75 407 87 0 0 0 0 0 0 0 0
Totale 6.396